daily oral glp-1 receptor agonist orforglipron for adults with obesity Oral GLP-1 confers up to
Description
Notably, a significant proportion (49.6%) of GLP-1 RAs users had already been on these medications prior to the index hospital discharge
[DOI] [PubMed] [Google Scholar] 94.Jin T
R., Barbieri, M., Marfella, R
It decreases the production of a hormone that opposes insulin called glucagon
Previous Serious Hypersensitivity Reaction: Patients who have had a severe allergic reaction (e.g., anaphylaxis or angioedema) to the specific GLP-1 agonist or any of its ingredients should not take it
